Bioaccess is Practice Management (Healthcare) in United States that focus on Medtech companies business. Founded in 2010. They cover business area such as operator, Medtech company, their clinical research project, Colombia, site selection, approval, your plan early-stage /early-feasibility, man, (fim)/first, concept, pharma, med-tech and biotech startup, clinical trial.
Practice Management (Healthcare)
2010
( 14 years old in 2024 )
Medtech Companies
-
2423 South Orange Avenue
Suite 321
Orlando, FL 32806
United States
Private
operatorMedtech companytheir clinical research projectColombiasite selectionapprovalyour plan early-stage /early-feasibilityman(fim)/firstconceptpharmamed-tech and biotech startupclinical trial
* We use standard office opening hours in near Bioaccess's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Bioaccess is Practice Management (Healthcare) business from United States that founded in 2010 (14 years old in 2024), Bioaccess business is focusing on Medtech Companies.
Bioaccess headquarter office and corporate office address is located in 2423 South Orange Avenue Suite 321 Orlando, FL 32806 United States.
Bioaccess was founded in United States.
In 2024, Bioaccess is currently focus on Medtech companies sector.
Above is snippet of Google Trends for "Medtech companies" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Bioaccess, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.